XML 26 R16.htm IDEA: XBRL DOCUMENT v3.8.0.1
REVENUE (Tables)
3 Months Ended
Mar. 31, 2018
REVENUE  
Schedule of significant changes in the contract assets

 

Significant changes in the contract assets balance during the three months ended March 31, 2018 was as follows (in thousands):

 

Outstanding at January 1, 2018

 

$

6,459

 

Increase (decrease) attributed to:

 

 

 

Transferred to receivables from contract assets recognized

 

(5,611

)

Product transferred over time

 

5,303

 

 

 

 

 

Outstanding at the end of period

 

$

6,151

 

 

 

 

 

 

 

Schedule of net sales by market

 

The following table summarizes our net sales by market for the three months ended March 31, 2018 (in thousands):

 

 

 

Product/
Service
Transferred
Over Time

 

Product
Transferred
at Point in
Time

 

Noncash
Consideration

 

Total Net
Sales by
Market

 

Aerospace and Defense

 

$

4,623

 

$

48

 

$

195

 

$

4,866

 

Medical

 

9,434

 

482

 

405

 

10,321

 

Industrial

 

9,992

 

843

 

425

 

11,260

 

 

 

 

 

 

 

 

 

 

 

Total net sales

 

$

24,049

 

$

1,373

 

$

1,025

 

$

26,447

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Schedule of consolidated statement of operations and comprehensive loss, balance sheet and cash flows, to the pro-forma amounts had the previous guidance been in effect

 

The following table compares the reported condensed consolidated statement of operations and comprehensive loss, balance sheet and cash flows, as of and for the three months ended March 31, 2018, to the pro-forma amounts had the previous guidance been in effect (in thousands):

 

 

 

Three Months Ended
March 31, 2018

 

 

 

As Reported

 

Pro forma as if
the previous
accounting
guidance was
in effect

 

Statement of Operations

 

 

 

 

 

Net Sales

 

$

26,447

 

$

25,730

 

Cost of Goods Sold

 

23,419

 

22,731

 

 

 

 

 

 

 

Gross Profit

 

3,028

 

2,999

 

 

 

 

 

 

 

Loss from Operations

 

(120

)

(149

)

 

 

 

 

 

 

Loss Before Income Taxes

 

(292

)

(321

)

 

 

 

 

 

 

Income Tax Expense

 

99

 

99

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Loss

 

$

(391

)

$

(420

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss Per Common Share Basic and Diluted

 

$

(0.14

)

$

(0.15

)

 

 

 

 

 

 

Consolidated Balance Sheet

 

 

 

 

 

Assets

 

 

 

 

 

Inventories

 

$

13,037

 

$

17,778

 

Contract Assets

 

6,151

 

$

 

 

 

 

 

 

 

Shareholders’ Equity

 

 

 

 

 

Retained Earnings

 

$

4,880

 

$

3,470

 

 

 

 

 

 

 

Consolidated Statement of Cash Flows

 

 

 

 

 

Net Loss

 

$

(391

)

$

(420

)

Adjustments to Reconcile Net Loss to Net Cash Provided by Operating Activities

 

 

 

 

 

Change in Current Operating Items

 

 

 

 

 

Inventories

 

229

 

566

 

Contract Asset

 

308

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Cash Provided by Operating Activities

 

$

542

 

$

542